OTCMKTS:CPMD CannaPharmaRX (CPMD) Stock Price, News & Analysis $0.0040 0.00 (-9.09%) As of 06/13/2025 11:09 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About CannaPharmaRX Stock (OTCMKTS:CPMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CannaPharmaRX alerts:Sign Up Key Stats Today's Range$0.0020▼$0.004050-Day Range N/A52-Week Range$0.0001▼$0.0155Volume14,500 shsAverage Volume181,701 shsMarket Capitalization$2.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.Read More… Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPMD Stock News HeadlinesCannaPharmaRX (OTCMKTS:CPMD) & Novartis (NYSE:NVS) Critical ContrastJune 13 at 1:56 AM | americanbankingnews.comContrasting CannaPharmaRX (OTCMKTS:CPMD) & Pacira BioSciences (NASDAQ:PCRX)June 8, 2025 | americanbankingnews.comStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors flee to gold, but Marc's found a better crisis hedge - monthly income from oil, not stocks.June 14, 2025 | The Oxford Club (Ad)CannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comPSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comCannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comSee More Headlines CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed this year? CannaPharmaRX's stock was trading at $0.0081 at the beginning of the year. Since then, CPMD stock has decreased by 50.6% and is now trading at $0.0040. View the best growth stocks for 2025 here. How were CannaPharmaRX's earnings last quarter? CannaPharmaRX, Inc. (OTCMKTS:CPMD) announced its quarterly earnings results on Thursday, April, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.48 million for the quarter. How do I buy shares of CannaPharmaRX? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CannaPharmaRX own? Based on aggregate information from My MarketBeat watchlists, some other companies that CannaPharmaRX investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI). Company Calendar Last Earnings4/10/2025Today6/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CPMD CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.69 million Net MarginsN/A Pretax Margin408.11% Return on EquityN/A Return on Assets-41.99% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-0.13Miscellaneous Outstanding Shares660,626,000Free Float652,236,000Market Cap$2.64 million OptionableNot Optionable Beta2.41 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:CPMD) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.